U.S. market Closed. Opens in 1 day 6 hours 31 minutes

LIAN | LianBio Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue1.00M525.70K76.13KN/A
Gross Profit-1.00M-525.70K-76.13KN/A
Operating Expenses125.35M195.57M134.87M24.38M
Selling, General & Admin65.60M36.88M13.98M1.72M
Research & Development59.76M158.69M120.89M22.66M
Other Operating Expenses10.41M-455.00K123.00KN/A
Operating Income-125.35M-195.57M-134.87M-24.38M
Other Expenses / Income14.73M-212.00K-4.73M10.02K
Before Tax Income-110.62M-195.78M-139.60M-24.37M
Income Tax Expenses-333.00K518.00K4.00K4.01K
Net Income-110.29M-196.30M-139.60M-24.37M
Interest ExpensesN/A243.00KN/AN/A
Basic Shares Outstanding107.92M34.39M105.26M108.30M
Diluted Shares Outstanding107.92M34.39M105.26M108.30M
EBITDA-124.35M-195.04M-134.79M-24.38M
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-110.62M-195.54M-139.60M-24.37M
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙